Navigation Links
Onconase has Potential as Chemopreventive Agent in Mesothelioma,,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting

BLOOMFIELD, N.J., April 18, 2007 /PRNewswire-FirstCall/ -- ONCONASE (ranpirnase), Alfacell Corporation's lead drug candidate, may have potential as a chemopreventive agent, according to world-renowned mesothelioma researcher Michele Carbone M.D., Ph.D., at this week's American Association for Cancer Research (AACR) Annual Meeting.

In a series of poster presentations, Dr. Carbone highlighted the growing worldwide problem of asbestos exposure and its link to malignant mesothelioma. Dr. Carbone presented data that show the early detection in patients at high risk for developing malignant mesothelioma is becoming more prevalent via the presence of certain biological markers in blood samples. Furthermore, he pointed out that ONCONASE's favorable toxicity profile and its well-documented mechanism of action, which directly affects the pathway that has been shown to cause asbestos carcinogenesis, position ONCONASE for potential early administration to populations "at-risk" for mesothelioma. If clinically validated, such a new approach might enable physicians to use ONCONASE as a chemopreventive agent to potentially prevent the onset of mesothelioma, or reduce the doses of cytotoxic agents needed in those patients who develop the disease.

"The potential of ONCONASE as an early first-line preventative treatment for mesothelioma is an exciting development that we plan to investigate through clinical trials," said Dr. Carbone. "With approximately more than 25 million asbestos exposure cases reported worldwide, we believe that ONCONASE might play a greater role in the treatment protocols for a much larger population than was originally envisioned for this dismal disease."

Dr. Carbone is a professor and director of the thoracic oncology program as well as a clinical professor of pathology with the University of Hawaii's Cancer Research Center of Hawaii, and chairman of the Alfacell Thoracic Advisory Boar
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Preclinical Data Show Alfacells Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
2. Researchers Identify Intracellular Pathway of Alfacells Onconase
3. In vivo Study Results Demonstrating Potential of Alfacells Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research
4. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
5. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. New Information on the Potential of Plasmin Shared at ISTH Congress
8. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
9. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

Post Your Comments:
(Date:11/5/2009)...RNewswire-FirstCall/ -- Virtual Health Technologie... that it has entered into a Letter of Intent to se...ent Technologies, Inc. (WNDM). The deal provides f...000,000 shares of WNDM stock and a royalty agreeme... $2.00 per share on 11/4/09 and VHGI closed at $0....
(Date:11/5/2009)...RNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ),...-Through Motion and Low-Perfusion pulse oximetry, ...study published in this month,s Inhalation Toxico...Pulse CO-Oximetry ( SpCO ) provides reliable meas... facilitate fast, accurate diagnosis of CO poison...
(Date:11/5/2009)... NeurogesX, Inc. (Nasdaq...developing and commercializing novel pain manageme... U.S. commercial operations team to include a Vice...and Director of Commercial Operations. ,, Ti...He will implement and manage the U.S. specialty sa...
Breaking Medicine Technology:OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010 2OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010 3New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood 2New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood 3New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood 4New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood 5NeurogesX Expands Commercial Operations Leadership Team 2NeurogesX Expands Commercial Operations Leadership Team 3NeurogesX Expands Commercial Operations Leadership Team 4NeurogesX Expands Commercial Operations Leadership Team 5NeurogesX Expands Commercial Operations Leadership Team 6Press alert for American Society of Nephrologys 42nd Annual Meeting and Scientific Exposition 59810 1Press alert for American Society of Nephrologys 42nd Annual Meeting and Scientific Exposition 59810 2K State receives more than 24780 000 to fund graduate students studying ecology evolution genomics 10432 1K State receives more than 24780 000 to fund graduate students studying ecology evolution genomics 10432 2UF receives 2412 2 million to establish national network of scientists 10429 1UF receives 2412 2 million to establish national network of scientists 10429 2UF receives 2412 2 million to establish national network of scientists 10429 3
(Date:11/5/2009)..., LOS ANGELES, Nov. 5 Narconon ...orked with its drug rehabilitation and education c... to speak with thousands of students and other com...ational Family Partnership,s (NFP) Red Ribbon Week...revention activities and is held during the end of...
(Date:11/5/2009)... UCSF HIV researchers have received two NIH grants... patient controlled personal health records to imp...sitive patients. , Both studies are funded throu...y and Reinvestment Act. , One study will look a...-based personal health record to help HIV patients...
(Date:11/5/2009)..., Teaneck, NJ/ - November 3, 2009 The Cornea an...ch study to determine if an investigational cornea... for reading glasses. Dr. Peter Hersh, the study ...stigational AcuFocus Corneal Inlay (ACI) is inten...opia, which is the loss of near vision, and reduce...
(Date:11/5/2009)... The goal of the “Ho...est is to increase awareness about the disease, ra...rch program through an online raffle and auction o...of ALS patients.” , ...-- As every caregiver who helps take care of someo...
(Date:11/5/2009)... Emdat, a world leader in ...dy Olver as its new CEO, effective immediately. ,...-- Emdat , a world leader in online-based medical...CEO, effective immediately., , , , ,Emdat’s...n the business, selected Olver to serve as CEO of ...
Breaking Medicine News(10 mins):Health News:Narconon Centers Educate Thousands During Red Ribbon Week 2Health News:Federal stimulus funds support studies geared to improving HIV care and prevention 2Health News:Near vision research study 2Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 2Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 3Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 4Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 5Health News:Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 2
...A new study published in the May issue of The Amer...lays an important role in males as well. Low level... hip fracture in men, the study found. Those who h..., and colleagues studying men from the National He...
...If breast cancer in women has occurred because of ...o seek remedy from a prevalent chemotherapy medica... ovarian and lung cancers, is getting known for it... mutations are twenty times more receptive to carb...
...PTSD is an anxiety disorder that develops after ex...vent. According to a study it was found that Vietn...rder (PTSD) //when compared with their non-combat ...ay predispose individuals to PTSD. The study was p...
...World’s first partial face transplant patient repo...t surgery done 5 months back//. Isabelle Din...r facial scars are more healed and she's recovered...or. Dinoire says her speech has improved, th...
...According to the research conducted by Professor D... Francisco it is found that computer users //suffe...e developed the simple forearm support which avoid... a year. They suffered less pain in the neck, shou...
...The medical students of the country are expected t...inst the reservation quota in professional college...al to hike reservation seats started on the 27th A...rike on May 2 will be a ‘‘show of strength’’ and s...
Other Medicine News:Health News:Hip Fracture Risk Increases In Men Having Low Estrogen Levels 2Health News:Brain Abnormalities Raise the Risk of PTSD 2Health News:Nationwide Strike on May 2nd by Medicos on Reservation Issue 2
...e rigid endoscopes for general applications and ar...e diameters of borescopes, i.e. rigid endoscopes, ...ons from 0 up to a 120 retrospection, and image an...ew. Endoscopes with working lengths of 1.5 meters ...
Neuroview 1.2 mm Neuroendoscopes
Neuroview Rigid Body Fiberoptic Neuroendoscopes
Preclude MVP Dura Substitute
Medicine Products: